
The recent approval of the first therapeutic cancer vaccine by the US Regulatory Agency represents a breakthrough event in the history of cancer zzso The past zzso towards this type of therapeutic intervention is now replaced by great zzso The field is now moving towards the development of alternative vaccination technologies, which are capable of generating stronger, more durable and efficient immune responses against specific zzso zzso zzso in combination with cheaper and more zzso zzso 

In this context, genetic vaccines are emerging among the most promising zzso Several zzso point to combinations of different genetic zzso zzso zzso zzso as a powerful approach to induce superior immune responses and achieve greater clinical zzso In this review, we provide an overview of the current status of development of genetic cancer vaccines with particular emphasis on zzso zzso zzso boost vaccination zzso 

We believe that therapeutic genetic cancer vaccines have the strong potential to become an established therapeutic zzso for cancer in next coming years, in a manner similar to what have now become zzso zzso 

